Moneycontrol PRO
Live now
auto refresh
Nov 20, 2023 / 09:44 am

Stock Market LIVE Updates: Sensex, Nifty trade marginally lower; IT, realty, pharma gain

Sensex Today | Stock Market LIVE Updates: Among sectors, IT, realty, pharma up 0.5 percent each, while selling is seen in the auto, bank and capital goods. Tata Investment Corporation, HDFC Bank, Axis Bank, Nykaa and Bajaj Finance are among the most active shares on the NSE.

  • Stock Market LIVE Updates: Sensex, Nifty trade marginally lower; IT, realty, pharma gain
    Stock Market Today
  • IndexPricesChangeChange%
    Sensex65,690.67-104.06 -0.16%
    Nifty 5019,717.50-14.30 -0.07%
    Nifty Bank43,472.50-111.45 -0.26%
    Nifty 50 19,717.50 -14.30 (-0.07%)
    Mon, Nov 20, 2023
    Biggest GainerPricesChangeChange%
    Divis Labs3,696.7595.90 +2.66%
    Biggest LoserPricesChangeChange%
    M&M1,567.40-17.15 -1.08%
    Best SectorPricesChangeChange%
    Nifty IT32526.20334.90 +1.04%
    Worst SectorPricesChangeChange%
    Nifty Infra6411.60-18.00 -0.28%

  • November 20, 2023 / 09:44 AM IST

    Stock Market LIVE Updates | L&T Technology Services Collaborates With NVIDIA

    L&T Technology Services Limited has announced a collaboration with NVIDIA to develop software-defined architectures for medical devices focused on endoscopy, which will enhance the image quality and scalability of products.

  • November 20, 2023 / 09:40 AM IST

    Stock Market LIVE Updates | Exide Industries settles long standing dispute on use of CHLORIDE mark in India with VCHL & VEPL

    The High Court has passed a decree by recording the terms of the Settlement Agreement executed by the parties namely Exide Industries, Vertiv Company Group Limited UK (VCGL), and Vertiv Energy (VEPL), while disposing-off the suits pending since 2006. Both VCGL & VEPL agreed that they will not use the said CHLORIDE mark in India, either directly or indirectly, and will withdraw all their claims over this mark in favour of EXIDE. There is no financial impact on the company on account of above settlement of the suits, as EXIDE was anyway using the said CHLORIDE mark in India for its electronic products (UPS) during the litigation period since 2006.

  • November 20, 2023 / 09:35 AM IST
    NSE Volume Shockers
    CompanyCMP Chg(%)Today Vol 5D Avg VolVol Chg(%)
    Prataap Snacks 934.80
    Summit Sec1,333.45
    Lexus Granito45.45
    Hb Stockhol90.90
    Talbros Auto278.25
    Arabian Petrole83.80
  • November 20, 2023 / 09:27 AM IST
    NSE Large Deals
    Alok Industries32890422.250.73
    Astra Microwave21224566.751.2
    Coal India33670350.21.18
    Jain Irrigation17526471.051.25
    JK Bank1830751142.09
    JSW Energy35518405.451.44
    JSW Energy25438404.51.03
  • November 20, 2023 / 09:19 AM IST

    Stock Market LIVE Updates | TCS announces record date for buyback

    Tata Consultancy Services has fixed Saturday, November 25, 2023 as the record date for the purpose of determining the buyback entitlement and the names of the equity shareholders who will be eligible to participate in the Buyback.

    The company to buyback up to 4,09,63,855 fully paid-up equity shares of face value of Rs 1 each at Rs 4,150 per equity share for an aggregate amount not exceeding RS 17,000 crore.

  • November 20, 2023 / 09:18 AM IST

    Stock Market LIVE Updates | USFDA concludes inspection of Aurobindo Pharma subsidiary's Telangana unit with zero observations

    The United States Food and Drug Administration (US FDA) concluded a pre-approval inspection (PAI) at Unit-I & III, formulation manufacturing facility of APL Healthcare, in Telangana, with zero observations. The inspection, which was conducted during November 13-17 closed with a classification of No Action Indicated (NAI). APL Healthcare is a subsidiary of Aurobindo Pharma.

  • November 20, 2023 / 09:18 AM IST

    Stock Market LIVE Updates | Cipla gets warning letter from USFDA for Pithampur manufacturing facility

    Cipla has received a Warning Letter dated 17th November, 2023 from United States Food and Drug Administration (USFDA) for the routine current Good Manufacturing Practices (cGMP) inspection conducted at its Pithampur manufacturing facility between 6th – 17th February, 2023.

    This Warning Letter summarizes contraventions regarding methods or controls followed at the facility which do not conform to the prescribed cGMP regulations and contains directional guidance for necessary corrections

    The pharma company has executed a Facility Demand Guarantee of ZAR 945 million in favour of First Rand Bank, South Africa, for extending general banking facilities to Medpro Pharmaceutica (Pty) Ltd. Medpro is a step down wholly owned subsidiary of Cipla in South Africa.

  • November 20, 2023 / 09:17 AM IST

    Gainers and Losers on the BSE Sensex in the early trade:

    SENSEX Market Map
  • November 20, 2023 / 09:15 AM IST

    Market Opens

    : Indian indices opened marginally lower on November 20 amid mixed gloabl cues.

    The Sensex was down 18.49 points or 0.03 percent at 65,776.24, and the Nifty was up 0.60 points or 0.00 percent at 19,732.40. About 1809 shares advanced, 555 shares declined, and 182 shares unchanged.

    Hindalco Industries, Apollo Hospitals, NTPC, Divis Labs and HCL Technologies were among major gainers on the Nifty, while losers were Axis Bank, Asian Paints, Kotak Mahindra Bank, Cipla and SBI Life Insurance.

  • November 20, 2023 / 09:12 AM IST

    Sensex Today | Ameya Ranadive, Research Analyst at Choice Broking:

    The benchmark Sensex and Nifty indices are anticipated to open with a slight decline on November 20, as indications from the GIFT Nifty suggest a negative commencement for the broader index.

    On November 17, both benchmarks concluded lower, with notable weakness observed in Bank Nifty, which closed 577 points lower at 43583.95, marking a crucial demand zone for the past seven months.

    Nifty encountered resistance in the range of 19850-19900 and has struggled to break out from these levels for the past two months, indicating a robust supply zone at this level.

    To facilitate an upward movement towards reclaiming levels of 20000-20200, NIFTY needs to surpass and sustain above 19850. Support is positioned at 19600-19400 levels.
    Conversely, Bank Nifty has support at 43370-43000, with resistance at 44000-44420 that must be breached for further upside.

    The selling activity by foreign institutional investors amounted to a net worth of Rs 477.76 crore, accompanied by domestic institutional investors offloading stocks worth Rs 565.48 crore on November 17, intensifying the downward pressure. It is advisable to adopt a stock-specific approach in today's trading session.

  • November 20, 2023 / 09:10 AM IST

    Sensex Today | Aditya Gaggar, Director of Progressive Shares:

    The markets settled the last day of the week on a tepid note at 19,731.80. We believe in the short run, the index will oscillate in a range where 19,850 will be a crucial resistance while the downside is protected at its strong support band of 19,550-19,580. In the case of BankNifty, the index is likely to retest its 200DMA support which comes around 43,250 while on the rise, it may face resistance at 44,060.

    The much-awaited breakout was seen in the Auto and Infra sectors which indicates a continuation of an uptrend (Bajaj Auto, Eicher Motors, Hero Motocorp, Capacite Infraprojects, ITD Cementation, and Welspun Enterprises). An uptrend in the Pharma segment will continue from hereon as well as it has given a breakout from a Pennant and Pole formation (Dr Reddy, Zydus, and LifeGranules). We are bullish on the stocks that were previously mentioned as well i.e. Alkem, IPCA Labs, and Sun Pharma. Railway stocks are hinting towards another round of a rally (Ircon, IRFC, Railtel, TexRail, RVNL).